title: Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomas.
abstract: OBJECTIVE
  GH-secreting pituitary adenomas frequently co-secrete prolactin and glycoprotein hormone alpha-subunit (alphaSU), but expression of additional hormones is considered unusual. The aim of this study was to establish the frequency with which acromegalic tumours secrete intact glycoprotein hormones LH, FSH and TSH, in comparison with other types of pituitary adenoma.
  
  
  METHODS
  Pituitary tumours were studied by cell culture, measuring the basal secretion of anterior pituitary hormones in vitro. Light microscopy was used to exclude tumours where normal pituitary tissue was present, and immunocytochemistry was employed to confirm the clinical diagnosis and for comparison with tissue culture data.
  
  
  RESULTS
  TSH secretion was observed in vitro in 15/23 somatotroph adenomas, but from only 1/8 lactotroph, 4/29 null cell, 2/12 gonadotroph and 1/10 corticotroph adenomas; moreover, somatotroph adenomas secreted the largest amounts of TSH (P < 0.(001). Somatotroph adenomas also secreted LH (7/23) and FSH (2/23) but less frequently than gonadotroph adenomas. Immunocytochemistry demonstrated glycoprotein expression in somatotroph adenomas (LHbeta: 13%, FSHbeta: 26%, TSHbeta: 30%, alphaSU: 46%) more frequently than in lactotroph, corticotroph and null cell adenomas. A strong correlation was found between alphaSU secretion and TSH secretion in somatotroph adenomas (rho= 0.683, P < 0.001.
  
  
  CONCLUSIONS
  TSHbeta is frequently expressed by somatotroph adenomas, often associated with alphaSU expression. Both GH and TSHbeta are dependent on the transcription factor, Pit-1, which is frequently expressed in somatotroph adenomas, although the expression of alphaSU requires an alternative explanation. Increased expression of alphaSU compared with TSHbeta may account for the secretion of free alphaSU by somatotroph adenomas.
authors.affiliation: Department of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, UK.
authors.forename: S J
authors.initials: SJ
authors.lastname: Aylwin
authors.forename: A
authors.initials: A
authors.lastname: King
authors.forename: A
authors.initials: A
authors.lastname: Blenke
authors.forename: J F
authors.initials: JF
authors.lastname: Geddes
authors.forename: D F
authors.initials: DF
authors.lastname: Wood
authors.forename: J P
authors.initials: JP
authors.lastname: Monson
authors.forename: J M
authors.initials: JM
authors.lastname: Burrin
mesh_terms: D000236:Adenoma / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D015292:Glycoprotein Hormones, alpha Subunit / Q000378:metabolism*; D019382:Human Growth Hormone / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D007986:Luteinizing Hormone / Q000378:metabolism; D010911:Pituitary Neoplasms / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism; D013972:Thyrotropin / Q000378:metabolism*; D014407:Tumor Cells, Cultured
chemical_list: D015292:Glycoprotein Hormones, alpha Subunit; D019382:Human Growth Hormone; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin